French COVID-19 cases, patient numbers ease as AstraZeneca inoculations start

PARIS (Reuters) - France on Saturday reported a fall in new COVID-19 infections and in the number of patients being treated in hospital, slightly easing pressure on the health system as the country rolled out shots with a third approved vaccine. The country registered 20,586 new confirmed COVID-19 cases, down from 22,139 the previous day and marking the third straight daily fall.

Reuters February 07, 2021 02:10:58 IST
French COVID-19 cases, patient numbers ease as AstraZeneca inoculations start

COVID-19 cases, patient numbers ease as AstraZeneca inoculations start" src="https://images.firstpost.com/wp-content/uploads/reuters/02-2021/07/2021-02-06T201913Z_1_LYNXMPEH150JI_RTROPTP_2_HEALTH-CORONAVIRUS-FRANCE-VACCINES.jpg" alt="French COVID19 cases patient numbers ease as AstraZeneca inoculations start" width="300" height="225" />

PARIS (Reuters) - France on Saturday reported a fall in new COVID-19 infections and in the number of patients being treated in hospital, slightly easing pressure on the health system as the country rolled out shots with a third approved vaccine.

The country registered 20,586 new confirmed COVID-19 cases, down from 22,139 the previous day and marking the third straight daily fall.

Hospitals were treating 27,369 people for the disease, down 245 from the previous day in a fourth consecutive daily fall.

The number of COVID-19 patients in intensive care eased to 3,225, down 20 from the previous day, data showed.

The government has resisted calls from health experts to impose a new national lockdown but the level of new cases per day has remained relatively steady above 20,000.

The number of people in France who have received their first dose of a COVID-19 vaccine has reached 1.86 million, with 247,260 having also received their second dose, the health ministry said.

France has received a batch of a COVID-19 vaccine developed by AstraZeneca, with 273,600 doses delivered, the ministry said in an statement.

The initial AstraZeneca shots are being reserved for health personnel under 65, with first injections taking place on Saturday.

A second batch of 304,800 doses will be delivered next week.

AstraZeneca is the third shot to be made available in France after Pfizer/BioNTech and Moderna.

France is relying on the AstraZeneca shot to accelerate a vaccination campaign criticised for a slow start. However, it may obtain fewer deliveries than initially hoped after production setbacks sparked a row between the company and the European Union.

The ministry reported 191 new deaths linked to COVID-19 , taking France's cumulative death toll in hospitals and nursing homes to 78,794.

(Reporting by Gus Trompiz and Caroline Pailliez, Editing by Timothy Heritage and Nick Macfie)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Subscribe to Moneycontrol Pro at ₹499 for the first year. Use code PRO499. Limited period offer. *T&C apply

also read

Robinhood now a go-to for young investors and short sellers
Business

Robinhood now a go-to for young investors and short sellers

By John McCrank NEW YORK (Reuters) - Robinhood, the online brokerage used by many retail traders to pile in to heavily shorted stocks like GameStop Corp, has made an ambitious push into loaning out its clients' shares to short sellers as it expands its business. The broker had $1.9 billion in shares loaned out as of Dec. 31, nearly three times the $674 million a year earlier, and it was permitted to lend out $4.6 billion worth of securities under margin agreements, around five times bigger than the prior year, according to an annual regulatory filing late on Monday

Wall Street mixed as Apple and Tesla retreat
Business

Wall Street mixed as Apple and Tesla retreat

By Noel Randewich (Reuters) - Wall Street was mixed on Tuesday, with Apple and Tesla losing ground, while materials and energy companies climbed as investors looked toward the U.S. Congress approving another stimulus package.

Biden's SEC nominee vows review of GameStop trading issues, climate disclosures
Business

Biden's SEC nominee vows review of GameStop trading issues, climate disclosures

By Pete Schroeder and Chris Prentice WASHINGTON (Reuters) - U.S. President Joe Biden's pick to head a key market regulator promised on Tuesday a thorough review of issues raised by the GameStop Corp stock frenzy and suggested companies may have to disclose their potential risks from climate change